Clinical Trials
3 trialsNCT06282874 2026-04-09
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Phase 4 Active not recruiting
NCT06230055 2025-11-25
Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis
Fudan University
Phase 4 Recruiting
NCT07092202 2025-07-29
Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4 Recruiting